In this MEDcast episode, Dr Chovatiya and Dr Bunick delve into the advancements in targeted treatments for vitiligo, exploring their potential to provide long-term efficacy and durable clinical response.
Back
Achieving Durable Clinical Response with Targeted Treatments for Vitiligo
In this MEDcast episode, Dr Chovatiya and Dr Bunick delve into the advancements in targeted treatments for vitiligo, exploring their potential to provide long-term efficacy and durable clinical response.
Achieving Durable Clinical Response with Targeted Treatments for Vitiligo
Episodes
All
All
In this MEDcast episode, Dr Chovatiya and Dr Bunick delve into the advancements in targeted treatments for vitiligo, exploring their potential to provide long-term efficacy and durable clinical response.
Advertisement
Advertisement
Trending on HCPLive
1
Vicadrostat EASi-KIDNEY Trial Discontinued for Lack of Benefit in CKD
2
ASH Issues New Ferritin Thresholds for Iron Deficiency Diagnosis
3
Atacicept Cuts IgAN Progression Risk 76% in ORIGIN 3 Final Data
4
Immediate Coronary Angiography Does Not Improve Survival Outcomes in Cardiac Arrest
5